203 related articles for article (PubMed ID: 22163166)
1. Novel mucus-penetrating liposomes as a potential oral drug delivery system: preparation, in vitro characterization, and enhanced cellular uptake.
Li X; Chen D; Le C; Zhu C; Gan Y; Hovgaard L; Yang M
Int J Nanomedicine; 2011; 6():3151-62. PubMed ID: 22163166
[TBL] [Abstract][Full Text] [Related]
2. Comparative study of Pluronic(®) F127-modified liposomes and chitosan-modified liposomes for mucus penetration and oral absorption of cyclosporine A in rats.
Chen D; Xia D; Li X; Zhu Q; Yu H; Zhu C; Gan Y
Int J Pharm; 2013 Jun; 449(1-2):1-9. PubMed ID: 23583840
[TBL] [Abstract][Full Text] [Related]
3. Mucus adhesion- and penetration-enhanced liposomes for paclitaxel oral delivery.
Liu Y; Yang T; Wei S; Zhou C; Lan Y; Cao A; Yang J; Wang W
Int J Pharm; 2018 Feb; 537(1-2):245-256. PubMed ID: 29288808
[TBL] [Abstract][Full Text] [Related]
4. The modulation of the permeability and the cellular uptake of liposome by stable anchoring of lipid-conjugated pluronic on liposome.
Kim JC; Chungt YI; Kim YH; Tae G
J Biomed Nanotechnol; 2014 Jan; 10(1):100-8. PubMed ID: 24724502
[TBL] [Abstract][Full Text] [Related]
5. Intestinal mucosa permeability following oral insulin delivery using core shell corona nanolipoparticles.
Li X; Guo S; Zhu C; Zhu Q; Gan Y; Rantanen J; Rahbek UL; Hovgaard L; Yang M
Biomaterials; 2013 Dec; 34(37):9678-87. PubMed ID: 24016855
[TBL] [Abstract][Full Text] [Related]
6. Pluronic F127-modified liposome-containing tacrolimus-cyclodextrin inclusion complexes: improved solubility, cellular uptake and intestinal penetration.
Zhu Q; Guo T; Xia D; Li X; Zhu C; Li H; Ouyang D; Zhang J; Gan Y
J Pharm Pharmacol; 2013 Aug; 65(8):1107-17. PubMed ID: 23837579
[TBL] [Abstract][Full Text] [Related]
7. The construction and characterization of hybrid paclitaxel-in-micelle-in-liposome systems for enhanced oral drug delivery.
Li Y; Chen Z; Cui Y; Zhai G; Li L
Colloids Surf B Biointerfaces; 2017 Dec; 160():572-580. PubMed ID: 29028605
[TBL] [Abstract][Full Text] [Related]
8. Interaction of cruciferin-based nanoparticles with Caco-2 cells and Caco-2/HT29-MTX co-cultures.
Akbari A; Lavasanifar A; Wu J
Acta Biomater; 2017 Dec; 64():249-258. PubMed ID: 29030304
[TBL] [Abstract][Full Text] [Related]
9. PEGylated Nanoemulsions for Oral Delivery: Role of the Inner Core on the Final Fate of the Formulation.
Santander-Ortega MJ; Plaza-Oliver M; Rodríguez-Robledo V; Castro-Vázquez L; Villaseca-González N; González-Fuentes J; Cano EL; Marcos P; Lozano MV; Arroyo-Jiménez MM
Langmuir; 2017 May; 33(17):4269-4279. PubMed ID: 28391698
[TBL] [Abstract][Full Text] [Related]
10. Oral mucus-penetrating PEGylated liposomes to improve drug absorption: Differences in the interaction mechanisms of a mucoadhesive liposome.
Yamazoe E; Fang JY; Tahara K
Int J Pharm; 2021 Jan; 593():120148. PubMed ID: 33290871
[TBL] [Abstract][Full Text] [Related]
11. Engineering of a novel pluronic F127/graphene nanohybrid for pH responsive drug delivery.
Hu H; Yu J; Li Y; Zhao J; Dong H
J Biomed Mater Res A; 2012 Jan; 100(1):141-8. PubMed ID: 21997951
[TBL] [Abstract][Full Text] [Related]
12. Recent progress in biomedical applications of Pluronic (PF127): Pharmaceutical perspectives.
Akash MS; Rehman K
J Control Release; 2015 Jul; 209():120-38. PubMed ID: 25921088
[TBL] [Abstract][Full Text] [Related]
13. Improved transport and absorption through gastrointestinal tract by PEGylated solid lipid nanoparticles.
Yuan H; Chen CY; Chai GH; Du YZ; Hu FQ
Mol Pharm; 2013 May; 10(5):1865-73. PubMed ID: 23495754
[TBL] [Abstract][Full Text] [Related]
14. Pulmonary delivery of mucus-traversing PF127-modified silk fibroin nanoparticles loading with quercetin for lung cancer therapy.
Tang Y; Zhang L; Sun R; Luo B; Zhou Y; Zhang Y; Liang Y; Xiao B; Wang C
Asian J Pharm Sci; 2023 Jul; 18(4):100833. PubMed ID: 37635802
[TBL] [Abstract][Full Text] [Related]
15. Goblet cell-targeting nanoparticles for oral insulin delivery and the influence of mucus on insulin transport.
Jin Y; Song Y; Zhu X; Zhou D; Chen C; Zhang Z; Huang Y
Biomaterials; 2012 Feb; 33(5):1573-82. PubMed ID: 22093292
[TBL] [Abstract][Full Text] [Related]
16. Cysteine modified and bile salt based micelles: preparation and application as an oral delivery system for paclitaxel.
Xu W; Fan X; Zhao Y; Li L
Colloids Surf B Biointerfaces; 2015 Apr; 128():165-171. PubMed ID: 25747310
[TBL] [Abstract][Full Text] [Related]
17. Mucus-penetrating nanoparticles: Promising drug delivery systems for the photodynamic therapy of intestinal cancer.
Anderski J; Mahlert L; Mulac D; Langer K
Eur J Pharm Biopharm; 2018 Aug; 129():1-9. PubMed ID: 29778525
[TBL] [Abstract][Full Text] [Related]
18. Folic acid-Pluronic F127 magnetic nanoparticle clusters for combined targeting, diagnosis, and therapy applications.
Lin JJ; Chen JS; Huang SJ; Ko JH; Wang YM; Chen TL; Wang LF
Biomaterials; 2009 Oct; 30(28):5114-24. PubMed ID: 19560199
[TBL] [Abstract][Full Text] [Related]
19. A functional drug delivery platform for targeting and imaging cancer cells based on Pluronic F127.
Zhang D; Tao L; Zhao H; Yuan H; Lan M
J Biomater Sci Polym Ed; 2015; 26(8):468-82. PubMed ID: 25780935
[TBL] [Abstract][Full Text] [Related]
20. Improved oral bioavailability of breviscapine via a Pluronic P85-modified liposomal delivery system.
Zhou Y; Ning Q; Yu DN; Li WG; Deng J
J Pharm Pharmacol; 2014 Jul; 66(7):903-11. PubMed ID: 24697705
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
